This 1-day course will cover state-of-the-art management of patients with cardiovascular risk factors. The course will highlight evidence-based recommendations for the management of patients with cardiovascular risk factors including those with co-morbidities such as diabetes, hypertension, and autoimmune conditions. The course will also review cardiovascular risk in patients with thyroid disorders, including heart failure with Graves disease, myxedema, and thyroid hormone replacement
A special research presentation on lipid droplet biology will highlight important ongoing research in lipid metabolism. The course will provide updates on the role of inflammation, hypertriglyceridemia, and lipoprotein(a) in cardiovascular disease risk. There will be an hour-long case conference with challenging cases in cardiovascular disease risk reduction. The course includes morning and afternoon panel discussion segments including an audience question-and-answer time
1.
When Should Immunocompromised Individuals Receive a COVID Booster?
2.
Home Screening Appeals to Women Facing Healthcare Barriers
3.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
4.
Prolonged Screen Time Linked to Sleep Issues in Preschoolers
5.
Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling
4.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
5.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
Recommended News For You
1.
'Converging' Evidence of Link Between Air Pollution and Breast Cancer
2.
A single bout of exercise gives results that could help cancer patients
3.
Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.
4.
Belzutifan Combo Could be Second-Line Option in Advanced RCC
5.
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study
Conferences That Might Interest You
Recommended Articles For You
1.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
2.
Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions
3.
Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients
4.
Emerging Frameworks in Oncology in Clinical Decision-Making
5.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation